Anlong Fund
Beijing, Beijinganlongmed.com
Overview
Anlong Fund is a venture capital firm based in China that focuses on early and growth-stage investments in the life sciences and healthcare sectors, including innovative bio-pharmaceuticals and medical devices. The fund targets the Chinese market, driven by factors like population aging and medical reform. It has at least two funds, Anlong I and Anlong II.
Portfolio Companies
9
Website
anlongmed.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. | Mar 2021 | Angel | Co-investor |
| Beijing Anlong Biopharmaceutical Co., Ltd. | Jan 2021 | VC Round | Co-investor |
| Beijing CorreGene Biotechnology Co., Ltd. | Dec 2019 | Angel | Co-investor |
| Suzhou Luodao Nanotechnology Co., Ltd. | Feb 2019 | Pre Seed | Co-investor |
| Lai Kai Pharmaceutical Technology | Jun 2018 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
